Form D Explorer

Form D — Avicenna Biosciences, Inc.

0001824034-25-000002 · filed Oct 30, 2025

Offering

Industry: Biotechnology
Exemptions: 06b
Total offering: $70,650
Total sold: $70,650
Minimum investment: $0
Investors: —
Sales commission: —
Finders' fees: —

Issuer

Name: Avicenna Biosciences, Inc.
CIK: 1824034
Entity: Corporation
Jurisdiction: DELAWARE
Year incorporated: —
Address: 101 W. CHAPEL HILL STREET, SUITE 210
DURHAM, NC 27701
Phone: 919-667-2504

Related persons

May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.

Christopher Meldrum · Executive Officer

Durham, NC Find on LinkedIn ↗
Thomas Kaiser · Executive Officer

Durham, NC Find on LinkedIn ↗
Pieter Burger · Executive Officer

Durham, NC Find on LinkedIn ↗
John Hamer · Director

Durham, NC Find on LinkedIn ↗
Dennis Langer · Director

Durham, NC Find on LinkedIn ↗

View the original filing on SEC EDGAR ↗